Uthman IW, Gharavi AE. Viral infections and antiphospholipid antibodies. Semin Arthritis Rheum. 2002;31(4):256–63.

Article  PubMed  Google Scholar 

Gharavi EE, Chaimovich H, Cucurull E, Celli CM, Tang H, Wilson WA, et al. Induction of antiphospholipid antibodies by immunization with synthetic viral and bacterial peptides. Lupus. 1999;8(6):449–55.

Article  CAS  PubMed  Google Scholar 

Gharavi AE, Pierangeli SS, Harris EN. Viral origin of antiphospholipid antibodies: endothelial cell activation and thrombus enhancement by CMV peptide-induced APL antibodies. Immunobiology. 2003;207(1):37–42.

Article  CAS  PubMed  Google Scholar 

Jaeger U, Kapiotis S, Pabinger I, Puchhammer E, Kyrle PA, Lechner K. Transient lupus anticoagulant associated with hypoprothrombinemia and factor XII deficiency following adenovirus infection. Ann Hematol. 1993;67(2):95–9.

Article  CAS  PubMed  Google Scholar 

Fox JP, Hall CE, Cooney MK. The Seattle Virus Watch. VII. Observations of adenovirus infections. Am J Epidemiol. 1977;105(4):362–86.

Article  CAS  PubMed  Google Scholar 

Walls T, Shankar AG, Shingadia D. Adenovirus: an increasingly important pathogen in pediatric bone marrow transplant patients. Lancet Infect Dis. 2003;3(2):79–86.

Article  PubMed  Google Scholar 

Shields AF, Hackman RC, Fife KH, Corey L, Meyers JD. Adenovirus infections in patients undergoing bone-marrow transplantation. N Engl J Med. 1985;312(9):529–33.

Article  CAS  PubMed  Google Scholar 

La Rosa AM, Champlin RE, Mirza N, Gajewski J, Giralt S, Rolston KV, et al. Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis. 2001;32(6):871–6.

Article  PubMed  Google Scholar 

Houbouyan L, Armengaud D, Leroy B, Roussi J, Gallet JP, Goguel A. Antiprothrombinase anticoagulant and acquired prothrombin deficiency in childhood viral pathology. Spontan Recover Arch Fr Pediatr. 1984;41:417–20.

CAS  Google Scholar 

Amiral J, Aronis S, Adamtziki E, Garoufi A, Karpathios T. Association of lupus anticoagulant with transient antibodies to prothrombin in a patient with hypoprothrombinemia. Thromb Res. 1997;86(1):73–8.

Article  CAS  PubMed  Google Scholar 

Male C, Lechner K, Eichinger S, Kyrle PA, Kapiotis S, Wank H, et al. Clinical significance of lupus anticoagulants in children. J Pediatr. 1999;134(2):199–205.

Article  CAS  PubMed  Google Scholar 

Schmugge M, Tölle S, Marbet GA, Laroche P, Meili EO. Gingival bleeding, epistaxis and haematoma three days after gastroenteritis: the haemorrhagic lupus anticoagulant syndrome. Eur J Pediatr. 2001;160(1):43–6.

Article  CAS  PubMed  Google Scholar 

Mizumoto H, Maihara T, Hiejima E, Shiota M, Hata A, Seto S, et al. Transient antiphospholipid antibodies associated with acute infections in children: a report of three cases and a review of the literature. Eur J Pediatr. 2006;165(7):484–8.

Article  CAS  PubMed  Google Scholar 

Knobe K, Tedgård U, Ek T, Sandström PE, Hillarp A. Lupus anticoagulants in two children–bleeding due to nonphospholipid-dependent antiprothrombin antibodies. Eur J Pediatr. 2012;171(9):1383–7.

Article  PubMed  Google Scholar 

Shimizu T, Ishiguro A, Takayanagi T, Matsui T, Tonegawa N, Maekawa T, et al. A case of lupus anticoagulant hypoprothrombinemia syndrome following adenovirus gastroenteritis and mycoplasma pneumonia. Nihon Rinsho Meneki Gakkai Kaishi. 2014;37(1):55–60 (Article in Japanese).

Article  CAS  PubMed  Google Scholar 

Gopalakrishnan V, Panginikkod S. Severe adenoviral pneumonia with transient lupus anticoagulant in an immunocompetent adult. J Hosp Med. 2016;11(Suppl 1): Abstract number 523. https://shmabstracts.org/abstract/severe-adenoviral-pneumonia-with-transient-lupus-anticoagulant-in-an-immunocompetent-adult/.

Greeno EW, Haake R, McGlave P, Weisdorf D, Verfaillie C. Lupus inhibitors following bone marrow transplant. Bone Marrow Transplant. 1995;15(2):287–91.

CAS  PubMed  Google Scholar 

Ritchie DS, Sainani A, D’Souza A, Grigg AP. Passive donor-to-recipient transfer of antiphospholipid syndrome following allogeneic stem-cell transplantation. Am J Hematol. 2005;79(4):299–302.

Article  CAS  PubMed  Google Scholar 

Massoud MR, William BM, Harrill K, Cooper BW, de Lima M, Schmaier AH. Transmission of lupus anticoagulant by allogeneic stem cell transplantation. Rev Bras Hematol Hemoter. 2014;36(4):287–9.

Article  PubMed  PubMed Central  Google Scholar 

Tenti S, Cheleschi S, Guidelli GM, Galeazzi M, Fioravanti A. Intravenous immunoglobulins and antiphospholipid syndrome: how, when and why? A review of the literature. Autoimmun Rev. 2016;15(3):226–35.

Article  CAS  PubMed  Google Scholar 

Schwab I, Nimmerjahn F. Intravenous immunoglobulin therapy: how does IgG modulate the immune system? Nat Rev Immunol. 2013;13(3):176–89.

Article  CAS  PubMed  Google Scholar 

Witherspoon RP, Storb R, Ochs HD, Fluornoy N, Kopecky KJ, Sullivan KM, et al. Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment. Blood. 1981;58(2):360–8.

Article  CAS  PubMed  Google Scholar 

Small TN, Robinson WH, Miklos DB. B cells and transplantation: an educational resource. Biol Blood Marrow Transplant. 2009;15(1 Suppl):104–13.

Article  PubMed  PubMed Central  Google Scholar 

Rand JH, Wolgast LR. Dos and don’ts in diagnosing antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program. 2012;2012:455–9.

Article  PubMed  Google Scholar 

Artim-Esen B, Pericleous C, Mackie I, Ripoll VM, Latchman D, Isenberg D, et al. Anti-factor Xa antibodies in patients with antiphospholipid syndrome and their effects upon coagulation assays. Arthritis Res Ther. 2015;7(17):47.

Article  Google Scholar 

Shen CY, Fu LS, Lin HK, Han SM, Wang JD. Macrohematuria as initial presentation in a girl with factor VIII and factor IX inhibitors associated with systemic lupus erythematosus. J Pediatr Hematol Oncol. 2012;34(8):e344–5.

Article  PubMed  Google Scholar 

Doma SA, Hillarp A, Pajič T, Andoljšek D, Černelč P, Zupan IP. Concurrent acquired inhibitors to factor VIII and IX, a laboratory artifact: a case report. Biochem Med (Zagreb). 2016;26(2):279–84.

Article  PubMed  Google Scholar 

Kazmi MA, Pickering W, Smith MP, Holland LJ, Savidge GF. Acquired haemophilia A: errors in the diagnosis. Blood Coagul Fibrinolysis. 1998;9(7):623–8.

Article  CAS  PubMed  Google Scholar 

Sahud M, Zhukov O, Mo K, Popov J, Dlott J. False-positive results in ELISA-based anti FVIII antibody assay may occur with lupus anticoagulant and phospholipid antibodies. Haemophilia. 2012;18(5):777–81.

Article  CAS  PubMed  Google Scholar 

Largo R, Sigg P, von Felten A, Straub PW. Acquired factor IX inhibitor in a non hemophiliac patient with autoimmune diseases. Br J Haematol. 1974;26:129–40.

Article  CAS  PubMed  Google Scholar 

Penmetsa GK, Rodgers GM, Smock KJ. Avoiding errors in the laboratory evaluation of potent lupus anticoagulants. Am J Hematol. 2010;85(4):272–4.

Article  PubMed  Google Scholar 

Rodriguez V, Reed AM, Kuntz NL, Anderson PM, Smithson WA, Nichols WL. Antiphospholipid syndrome with catastrophic bleeding and recurrent ischemic strokes as initial presentation of systemic lupus erythematosus. J Pediatr Hematol Oncol. 2005;27(7):403–7.

Article  PubMed  Google Scholar 

Humbert P, Gutknecht J, Mallet H, Dupond JL, Leconte des Floris R. Tranexamic acid and thrombosis of the superior longitudinal sinus. Therapie. 1987;42(1):65–6.

CAS  PubMed